Blood Podcast cover image

Primary resistance to BCMA-targeted bispecifics in multiple myeloma, emapalumab therapy in hemophagocytic lymphohistiocytosis, and chemotherapy-induced pyroptosis as a mechanism of thrombus formation in patients with cancer

Blood Podcast

00:00

Exploring Resistance Mechanisms in Hematological Therapies and Chemotherapy-Induced Thrombosis

This chapter explores key developments in hematological treatments, focusing on resistance mechanisms in multiple myeloma and the promising outcomes of emipalumab for pediatric hemophagocytic lymphohistiocytosis. It also discusses the potential therapeutic applications of GSDME-mediated pyroptosis in reducing chemotherapy-related thrombotic risks.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app